[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.19.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editorial
April 2001

One-Stop ShoppingStroke Questions Further Answered With Magnetic Resonance Imaging

Arch Neurol. 2001;58(4):555-556. doi:10.1001/archneur.58.4.555

IN THE traditional approach to managing stroke, questions that need to be asked and answered include the following: Who is at risk for stroke? What can we do about both preventing and treating stroke? Where is the brain injured? Where in the vascular system is the problem? Why, pathophysiologically, has this stroke occurred? and How (and when) do we implement therapies to minimize neurological disability? While hyperacute therapy with intravenous recombinant tissue-type plasminogen activator (rt-PA) is the most significant therapy to date that improves neurological outcome, it remains a potentially dangerous intervention.

First Page Preview View Large
First page PDF preview
First page PDF preview
×